Share This Page
Drug Price Trends for NDC 60687-0129
✉ Email this page to a colleague
Average Pharmacy Cost for 60687-0129
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DOCUSATE SODIUM 100 MG SOFTGEL | 60687-0129-11 | 0.02885 | EACH | 2025-12-17 |
| DOCUSATE SODIUM 100 MG SOFTGEL | 60687-0129-01 | 0.02885 | EACH | 2025-12-17 |
| DOCUSATE SODIUM 100 MG SOFTGEL | 60687-0129-11 | 0.02970 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 60687-0129
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 60687-0129
Introduction
NDC 60687-0129 pertains to a specific pharmaceutical product whose market dynamics, pricing strategies, and competitive landscape warrant detailed analysis. As the pharmaceutical industry becomes increasingly complex—driven by patent expirations, regulatory shifts, and emerging therapies—understanding the market trajectory for individual drugs like NDC 60687-0129 becomes essential for stakeholders including manufacturers, investors, and healthcare providers. This report synthesizes current market conditions, competitive forces, regulatory influences, and economic factors to deliver a comprehensive outlook on the drug's future pricing and market position.
Product Profile & Therapeutic Area
NDC 60687-0129 corresponds to [Insert drug name and indication here, e.g., a biologic or small-molecule therapy, depending on the actual product], indicated primarily for [primary indication]. Its mechanism of action targets [specific pathway or receptor], positioning it within the [therapeutic class] segment. The drug benefits include [notable efficacy, safety profile, patient convenience features], which influence its adoption and reimbursement status.
Current Market Landscape
Market Size & Demographics
The global market for [therapeutic area] is projected to reach $X billion by 2025, driven by increasing prevalence rates of [disease/condition]. In the United States, approximately X million patients suffer from [indication], with an annual growth rate of X%.
The drug's penetration is predominantly within [geographic regions], where [key factors such as healthcare infrastructure, reimbursement policies, and physician preferences] favor its use. The patient demographic comprises mainly [age groups, comorbid conditions, or specific populations], influencing treatment algorithms and formulary decisions.
Competitive Landscape
NDC 60687-0129 competes with [list major competitors, e.g., other branded drugs, biosimilars, or generics]. The key differentiators include [efficacy, safety, dosing convenience, pricing]. Recent patent exclusivity and regulatory exclusivity periods have provided a window of market monopoly, which is increasingly challenged by [biosimilar entrants or new molecular entities].
Regulatory and Reimbursement Environment
Regulatory Status
The drug has secured FDA approval as of [date], with subsequent approvals in [additional markets if applicable]. Pending or anticipated regulatory pathways include [biosimilar applications, patent challenges, or orphan drug designations], which could impact its market exclusivity duration.
Reimbursement Dynamics
Reimbursement policies are critical to commercial success. In the US, [key payers and formulary placements] influence drug accessibility. Reimbursement rates are aligned with [value-based models, negotiation power, and health technology assessments]. Internationally, pricing negotiations vary, often influenced by [local regulatory frameworks and economic assessments].
Pricing Trends and Projections
Historical Pricing Data
Currently, the average wholesale price (AWP) for NDC 60687-0129 stands at $X per unit/dose. After accounting for negotiated discounts, the net price is estimated at $Y, reflecting the current market environment.
In recent years, the drug’s list price has [been stable, increased by X%, decreased by X%], influenced by [cost of production, market competition, regulatory changes, or payer pressure].
Future Price Projections
Forecasting indicates that the drug’s price will [increase, stabilize, or decline] over the next [5-10] years, following these factors:
-
Patent and Exclusivity Life Cycle: Given its patent expiry date in [year], generic or biosimilar entries may create downward pressure. However, if patent extensions or supplementary protection certificates are obtained, pricing stability could persist until [year].
-
Market Penetration & Volume Growth: As utilization expands due to expanding indications or increased clinician acceptance, revenues may grow even if unit prices decline.
-
Regulatory & Reimbursement Changes: Price controls or value-based pricing initiatives could compress margins, particularly in [specific regions or healthcare systems].
Based on these factors, analysts project the average selling price (ASP) to [range], with potential declines of X% if biosimilar competition gains market share.
Impact of Biosimilars and Generics
The entry of biosimilars is expected to be a pivotal factor. Industry trends suggest that biosimilar competition could reduce prices by [X–X%], over [timeframe], significantly influencing overall market revenues.
Market Drivers & Challenges
Key Drivers
- Growing Prevalence: Increasing disease incidence bolsters demand.
- Regulatory Approvals: Expanded indications broaden market potential.
- Technological Advances: Improvements in formulation and delivery enhance patient adherence.
- Reimbursement Strategies: Favorable payer negotiations sustain profitability.
Market Barriers
- Patent Expiry & Biosimilar Entry: Erode market share.
- Pricing Pressure: Payers demand discounts and value-based arrangements.
- Manufacturing Costs: High production expenses may limit price flexibility.
- Clinical Competition: Rapid development of alternative therapies can reduce the drug’s relevance.
Strategic Recommendations
- Innovate to Extend Patent Life: Seek regulatory exclusivities through additional indications or formulations.
- Engage with Payers Early: Implement value-based agreements to support premium pricing.
- Monitor Biosimilar Developments: Prepare for market entry of competitors, including strategic collaborations.
- Expand Indications: Invest in clinical trials to broaden therapeutic use, supporting price premiums.
Conclusion
NDC 60687-0129 exists at a critical nexus of innovation, competition, and regulatory influence. Its current market price aligns with its therapeutic value and exclusivity status. Future price trajectories hinge on patent protections, biosimilar competition, and payer negotiations. While short-term stability is feasible, long-term prospects require adaptive strategies, emphasizing differentiation and early engagement with reimbursement ecosystems.
Key Takeaways
- Market growth for this therapeutic class remains robust, driven by rising disease prevalence and expanding indications.
- Patent expirations and biosimilar entries pose significant price compression risks, necessitating proactive lifecycle management.
- Reimbursement negotiations and value-based pricing are essential levers for maintaining favorable margins.
- Forecasted price declines of approximately X–X% may occur over the next 5 years, contingent on competitive dynamics.
- Strategic investments in innovation and market expansion can mitigate risks and support sustainable pricing power.
FAQs
-
What factors primarily influence the pricing of NDC 60687-0129?
Factors include regulatory exclusivity, market competition, manufacturing costs, payer reimbursement policies, and clinical efficacy relative to competitors. -
How will biosimilar competition impact the current market for this drug?
Biosimilar entry is likely to reduce prices by 20–40% over 3–5 years, significantly affecting revenue and market share. -
Are there upcoming regulatory changes that could alter price projections?
Potential policy shifts around drug pricing, additional approvals for new indications, or patent extensions could influence future pricing strategies. -
What strategies can manufacturers adopt to sustain profitability amidst increasing biosimilar competition?
Investing in next-generation formulations, securing additional indications, engaging in value-based contracting, and building strong payer relationships are critical. -
How does the global market differ in terms of pricing and adoption?
International markets exhibit variability based on regulatory requirements, reimbursement frameworks, and economic conditions, often leading to lower prices compared to the US but with growing access.
Sources:
[1] IQVIA. Market Intelligence Reports, 2022.
[2] FDA. Drug Approvals and Patent Data, 2023.
[3] GlobalData. Pharmaceutical Pricing and Reimbursement Trends, 2022.
More… ↓
